Financials Corbion N.V.

Equities

CRBN

NL0010583399

Specialty Chemicals

Market Closed - Euronext Amsterdam 11:35:15 2024-07-08 am EDT After market 12:26:41 pm
19.41 EUR +0.21% Intraday chart for Corbion N.V. 19.38 -0.18%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,652 2,715 2,443 1,879 1,149 1,145 - -
Enterprise Value (EV) 1 1,956 2,999 2,904 1,879 1,864 1,628 1,605 1,549
P/E ratio 65.4 x 37.5 x 31.4 x 21.1 x 15.9 x 19.4 x 13.1 x 10.8 x
Yield 1.99% 1.21% 1.35% - 3.15% 3.25% 3.2% 3.51%
Capitalization / Revenue 1.69 x 2.75 x 2.28 x 1.29 x 0.8 x 0.85 x 0.82 x 0.79 x
EV / Revenue 2 x 3.04 x 2.71 x 1.29 x 1.29 x 1.21 x 1.15 x 1.07 x
EV / EBITDA 13.4 x 18.9 x 21.4 x 10.2 x 9.72 x 9.73 x 7.52 x 6.63 x
EV / FCF 204 x 149 x -23 x - 116 x 30.4 x 31.5 x 24 x
FCF Yield 0.49% 0.67% -4.35% - 0.86% 3.29% 3.18% 4.16%
Price to Book 3.12 x 5.27 x 4.41 x - 1.8 x 1.73 x 1.6 x 1.46 x
Nbr of stocks (in thousands) 58,765 58,820 58,952 59,013 59,273 59,091 - -
Reference price 2 28.12 46.15 41.44 31.84 19.38 19.37 19.37 19.37
Announcement Date 3/9/20 3/5/21 2/25/22 3/3/23 3/1/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 976.4 986.5 1,071 1,458 1,444 1,343 1,401 1,447
EBITDA 1 145.9 158.8 135.8 184.4 191.8 167.3 213.5 233.6
EBIT 1 85 98.5 71.7 108 107.2 88.46 128.6 150.3
Operating Margin 8.71% 9.98% 6.7% 7.41% 7.42% 6.59% 9.18% 10.39%
Earnings before Tax (EBT) 1 44.7 87.7 86.5 116.4 85.3 83.55 111.3 134.4
Net income 1 25.8 73.1 78.3 90 72.9 53.22 90.88 105.7
Net margin 2.64% 7.41% 7.31% 6.17% 5.05% 3.96% 6.49% 7.31%
EPS 2 0.4300 1.230 1.320 1.510 1.220 1.000 1.480 1.790
Free Cash Flow 1 9.6 20.1 -126.3 - 16.1 53.53 51 64.5
FCF margin 0.98% 2.04% -11.79% - 1.12% 3.99% 3.64% 4.46%
FCF Conversion (EBITDA) 6.58% 12.66% - - 8.39% 31.99% 23.89% 27.61%
FCF Conversion (Net income) 37.21% 27.5% - - 22.09% 100.58% 56.12% 61.02%
Dividend per Share 2 0.5600 0.5600 0.5600 - 0.6100 0.6300 0.6200 0.6800
Announcement Date 3/9/20 3/5/21 2/25/22 3/3/23 3/1/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2020 S1 2021 S1 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2023 Q2 2023 S1 2023 Q3
Net sales 1 492.2 515.6 282 273.2 320.1 367.3 378.4 - 353
EBITDA 1 83.8 77.1 36.4 22.3 40 - 48.4 - 39.3
EBIT 45.7 70.3 - - - 28.9 - 53.6 -
Operating Margin 9.28% 13.63% - - - 7.87% - - -
Earnings before Tax (EBT) - - - - - - - - -
Net income - - - - - - - - -
Net margin - - - - - - - - -
EPS - - - - - - - - -
Dividend per Share - - - - - - - - -
Announcement Date 8/7/20 8/10/21 10/27/21 2/25/22 4/29/22 8/10/22 8/10/23 8/10/23 10/26/23
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 303 284 461 - 715 484 460 404
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 2.079 x 1.79 x 3.395 x - 3.729 x 2.89 x 2.157 x 1.731 x
Free Cash Flow 1 9.6 20.1 -126 - 16.1 53.5 51 64.5
ROE (net income / shareholders' equity) 8.77% 14% 14.6% - 10.8% 8.8% 12.6% 14.3%
ROA (Net income/ Total Assets) 4.47% 6.75% - - - - - -
Assets 1 576.8 1,083 - - - - - -
Book Value Per Share 2 9.000 8.760 9.400 - 10.80 11.20 12.10 13.30
Cash Flow per Share 2 1.940 1.850 0.3800 - 2.800 2.600 3.170 3.390
Capex 1 82.6 88.9 149 - 149 109 111 121
Capex / Sales 8.46% 9.01% 13.89% - 10.34% 8.1% 7.95% 8.39%
Announcement Date 3/9/20 3/5/21 2/25/22 3/3/23 3/1/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
19.37 EUR
Average target price
23.65 EUR
Spread / Average Target
+22.10%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. CRBN Stock
  4. Financials Corbion N.V.